MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
888.01%
Quick Ratio
796.08%
Cash Ratio
170.34%
Debt to Asset Ratio
12.32%
Unit: Thousand (K) dollars
Assets Breakdown
Short-term investments
Long-term investments
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
44,318
30,206
31,576
38,485
Restricted cash, current
100
100
100
-
Short-term investments
136,171
169,314
187,549
190,202
Accounts receivable, net
18,053
15,750
17,118
11,539
Inventories
23,918
23,727
21,722
20,373
Prepaid expenses and other current assets
8,474
8,889
9,840
9,427
Total current assets
231,034
247,986
267,905
270,026
Total cost
17,797
16,500
14,355
13,673
Less accumulated depreciation and amortization
7,049
6,340
5,755
6,288
Property and equipment, net
10,748
10,160
8,600
7,385
Operating lease right-of-use asset
5,816
6,225
6,627
7,024
Restricted cash
-
-
-
100
Long-term investments
44,648
39,865
45,431
45,328
Other long-term assets
141
181
180
183
Total assets
292,387
304,417
328,743
330,046
Accounts payable
5,351
2,318
4,998
4,461
Accrued expenses and other current liabilities
17,194
17,329
22,431
17,605
Operating lease liabilities
1,591
1,839
1,938
1,980
Deferred revenue
1,881
1,705
1,557
1,342
Total current liabilities
26,017
23,191
30,924
25,388
Operating lease liabilities, net of current portion
4,921
5,073
5,365
5,707
Deferred revenue, net of current portion
3,454
3,350
3,297
2,986
Other long-term liabilities
1,629
1,558
1,547
1,205
Total liabilities
36,021
33,172
41,133
35,286
Common stock-Common Class A
-
-
-
0
Common stock-Common Class B
-
-
-
0
Common stock-Common Class C
-
-
-
0
Preferred stock
-
-
0
0
Common stock
5
5
4
4
Additional paid-in capital
671,986
663,168
657,140
650,873
Accumulated other comprehensive income (loss)
-390
-96
403
354
Accumulated deficit
-415,235
-391,832
-369,937
-356,471
Total stockholders' equity
256,366
271,245
287,610
294,760
Total liabilities and stockholders' equity
292,387
304,417
328,743
330,046
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$136,171K
(-36.56%↓ Y/Y)
Cash and cash
equivalents
$44,318K
(26.35%↑ Y/Y)
Inventories
$23,918K
(38.07%↑ Y/Y)
Accounts receivable, net
$18,053K
(58.43%↑ Y/Y)
Prepaid expenses and
other current assets
$8,474K
(10.96%↑ Y/Y)
Restricted cash, current
$100K
Total cost
$17,797K
(43.92%↑ Y/Y)
Total current assets
$231,034K
(-19.24%↓ Y/Y)
Long-term investments
$44,648K
(43.34%↑ Y/Y)
Property and equipment,
net
$10,748K
(66.25%↑ Y/Y)
Operating lease
right-of-use asset
$5,816K
(-3.68%↓ Y/Y)
Other long-term
assets
$141K
(-2.08%↓ Y/Y)
Less accumulated
depreciation and...
$7,049K
(19.45%↑ Y/Y)
Total assets
$292,387K
(-11.39%↓ Y/Y)
Total liabilities and
stockholders' equity
$292,387K
(-11.39%↓ Y/Y)
Total stockholders'
equity
$256,366K
(-15.01%↓ Y/Y)
Total liabilities
$36,021K
(27.11%↑ Y/Y)
Accumulated deficit
-$415,235K
(-21.32%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$390K
(-361.74%↓ Y/Y)
Additional paid-in capital
$671,986K
(4.39%↑ Y/Y)
Total current
liabilities
$26,017K
(33.50%↑ Y/Y)
Operating lease
liabilities, net of current...
$4,921K
(-4.78%↓ Y/Y)
Deferred revenue, net of
current portion
$3,454K
(29.36%↑ Y/Y)
Other long-term
liabilities
$1,629K
(61.13%↑ Y/Y)
Common stock
$5K
(25.00%↑ Y/Y)
Accrued expenses and
other current...
$17,194K
(28.27%↑ Y/Y)
Accounts payable
$5,351K
(56.28%↑ Y/Y)
Deferred revenue
$1,881K
(64.86%↑ Y/Y)
Operating lease
liabilities
$1,591K
(4.74%↑ Y/Y)
Buy us a coffee
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)